Avoid common mistakes on your manuscript.
Dear Editor,
We would like to correspond on the publication “COVID-19 vaccination in lung transplant recipients. [1]”. Corona virus disease-19 (COVID-19) vaccination in transplant recipients generates a lower protective response when compared to immunocompetent hosts, according to Altneu and Mishkin [1]. The appropriate number of COVID doses and timing, according to Altneu and Mishkin, is still unknown, with new findings pointing to the requirement for a fourth mRNA vaccine [1]. We agree that COVID-19 vaccination is beneficial to lung transplant recipients, and clinical evidence backs this up. However, the likely effect of asymptomatic COVID-19 is a significant confounding factor in several studies. Infection with COVID-19 is common, and the virus can re-infect people without generating symptoms [2]. COVID-19 may become asymptomatic, making the efficacy of the vaccination in past trials more difficult to establish due to immunological abnormalities. The potential of asymptomatic COVID-19 must be ruled out before a firm determination can be reached. Regardless of whether COVID-19 is asymptomatic, the immunisation can induce immunity. For transplant recipients, a booster immunisation is frequently required. The fourth dosage of COVID-19 vaccination is presently being administered to the general public in various countries, including Israel. The use of the fourth dosage of COVID-19 vaccination is also beneficial, according to a prior study [3]. As a result, lung transplant recipients may consider receiving a fourth dose of COVID-19 vaccination.
References
Altneu E, Mishkin A. COVID-19 Vaccination in Lung Transplant Recipients. Indian J Thorac Cardiovasc Surg. 2022. https://doi.org/10.1007/s12055-022-01364-9.
Joob B, Wiwanitkit V. Letter to the Editor: Coronavirus disease 2019 (COVID-19), infectivity, and the incubation period. J Prev Med Public Health. 2020;53:70.
Mungmunpuntipantip R, Wiwanitkit V. Fourth dose of COVID-19 vaccine: does it still contribute any additional immunoprotection? J Taibah Univ Med Sci. 2022;17:533–6. https://doi.org/10.1016/j.jtumed.2022.04.004.
Funding
None.
Author information
Authors and Affiliations
Ethics declarations
Ethical approval
Not applicable.
Informed consent
Not applicable.
Conflict of interest
None.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mungmunpuntipantip, R., Wiwanitkit, V. COVID-19 vaccination and lung transplant recipients. Indian J Thorac Cardiovasc Surg 38 (Suppl 2), 354 (2022). https://doi.org/10.1007/s12055-022-01385-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12055-022-01385-4